常山生化药业（江苏）有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
8
NMPA:8
Drug Approvals
Sildenafil Citrate Tablets
- Product Name
- 枸橼酸西地那非片
- Approval Number
- 国药准字H20171004
- Approval Date
- May 6, 2022
NMPA
Dalteparin Sodium Injection
- Product Name
- 达肝素钠注射液
- Approval Number
- 国药准字H20213489
- Approval Date
- Jun 16, 2021
NMPA
Irbesartan and Hydrochlorothiazide tablets
- Product Name
- 厄贝沙坦氢氯噻嗪片
- Approval Number
- 国药准字H20113240
- Approval Date
- Mar 16, 2021
NMPA
Low Molecular Weight Heparin Calcium
- Product Name
- 低分子量肝素钙
- Approval Number
- 国药准字H19990077
- Approval Date
- Jun 24, 2020
NMPA
Gliclazide modified Release Tablets
- Product Name
- 格列齐特缓释片
- Approval Number
- 国药准字H20093409
- Approval Date
- Mar 7, 2019
NMPA
Galanthamine Hydrobromide Tablets
- Product Name
- 慧敏
- Approval Number
- 国药准字H20040113
- Approval Date
- Jul 14, 2015
NMPA
Clinical Trials
No trials found
News
No news found